@prino_booktok: ☕🍂 NEWS & BREWS | Autumn Edition A new weight-loss drug is outperforming Ozempic, and a popular supplement has just been recalled. Are you keeping up? This week, Eli Lilly's experimental drug retatrutide is making headlines after reporting greater weight loss and improved blood sugar control compared with Ozempic in a clinical trial. But there's more you need to know! Whole Foods has recalled certain ashwagandha capsules over possible Salmonella contamination. New research explores how different stages of a woman's life may reveal important clues about heart health. Scientists are investigating whether changes in your voice could help identify signs of accelerated brain aging. And we're covering a new Salmonella investigation, along with simple everyday habits that support a healthier heart. Here's the thing: Not every health headline should scare you. Some should inform you, some should inspire you, and others might just change how you care for yourself. ☕ Grab your favorite brew, catch up on what matters, and tell us: Which story surprised you the most? #NewsAndBrews #SolidarityWellness #HealthNews #GLP1 #MindBodyBalance

714

There are no more comments for this video.

To see more videos from user @prino_booktok, please go to the Tikwm homepage.